Effect of Combined Morphine and Duloxetine on Chronic Pain
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
A double-blind, randomized, and placebo-controlled clinical study examining whether
duloxetine, a serotonin and norepinephrine reuptake inhibitor (SNRI), could enhance opioid
analgesia and reduce overall opioid use. Positive outcomes will help improve the overall
effectiveness of clinical opioid therapy and reduce unnecessary opioid dose escalation.